ETF DAILY NEWS

Nuvation Bio Inc. (NYSE:NUVB) Given Average Rating of “Buy” by Brokerages

Shares of Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) have been assigned an average rating of “Buy” from the six analysts that are presently covering the company, MarketBeat reports. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month […]

May 23, 2025 - 08:12
 0
Nuvation Bio Inc. (NYSE:NUVB) Given Average Rating of “Buy” by Brokerages
Shares of Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) have been assigned an average rating of “Buy” from the six analysts that are presently covering the company, MarketBeat reports. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month […]
Read More

Tags:

Previous Article

Haemonetics’ (HAE) “Market Outperform” Rating Reiterated at JMP Securities

Next Article

Cameco (NYSE:CCJ) Earns Buy Rating from Analysts at The Goldman Sachs Group

Related Posts

Desjardins Predicts Stella-Jones’ FY2025 Earnings (TSE:SJ)

Desjardins Predicts Stella-Jones’ FY2025 Earnings (TSE:SJ)

May 13, 2025  0

Ameriprise Financial Inc. Has $18.48 Million Holdings in Crocs, Inc. (NASDAQ:CROX)

Ameriprise Financial Inc. Has $18.48 Million Holdings i...

May 16, 2025  0

Price T Rowe Associates Inc. MD Trims Stock Holdings in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)

Price T Rowe Associates Inc. MD Trims Stock Holdings in...

May 18, 2025  0